Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL9 | O00512 | 1/20 | 0.44 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.41 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.41 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | MGLL | Q99685 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9679112 | 0.75 | ALDH1A1 (0.45) | BCL9CTNNB1SMN1; SMN2ALDH1A1GAA | |
| SCHEMBL20377184 | 0.74 | SMN1; SMN2 (0.64) | BCL9CTNNB1SMN1; SMN2ALDH1A1GAA | |
| SCHEMBL6322393 | 0.74 | SMN1; SMN2 (0.64) | BCL9CTNNB1SMN1; SMN2ALDH1A1GAA | |
| SCHEMBL3176066 | 0.74 | GAA (0.61) | BCL9CTNNB1SMN1; SMN2ALDH1A1GAA | |
| SCHEMBL6858793 | 0.73 | GAA (0.56) | BCL9CTNNB1SMN1; SMN2ALDH1A1GAA | |
| SCHEMBL8816649 | 0.72 | ALDH1A1 (0.52) | BCL9CTNNB1SMN1; SMN2ALDH1A1GAA | |
| SCHEMBL28989406 | 0.72 | MGLL (0.58) | BCL9CTNNB1SMN1; SMN2ALDH1A1GAA | |
| Malonic Acid SCHEMBL3800103 | 0.72 | BCL9 (0.55) | BCL9CTNNB1SMN1; SMN2ALDH1A1GAA | |
| SCHEMBL17236217 | 0.71 | BCL9 (0.59) | BCL9CTNNB1SMN1; SMN2ALDH1A1GAA | |
| SCHEMBL26374 | 0.71 | GAA (0.65) | BCL9CTNNB1SMN1; SMN2ALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2033661-A1 | Methods of screening affinity marker libraries | ConjuChem Biotechnologies Inc. (CA) | 2009-03-11 | — | — | EP | disclosed |
| EP-1199566-B1 | Methods of screening affinity marker libraries | CONJUCHEM BIOTECHNOLOGIES INC (CA) | 2008-08-27 | — | — | EP | disclosed |
| US-7166695-B2 | Affinity markers for human serum albumin | CONJUCHEM BIOTECHNOLOGIES INC. (CA) | 2007-01-23 | — | — | US | disclosed |
| US-20050037974-A1 | Affinity markers for human serum albumin | CONJUCHEM, INC. (CA) | 2005-02-17 | — | — | US | disclosed |
| EP-1056474-B1 | AFFINITY MARKERS FOR HUMAN SERUM ALBUMIN | CONJUCHEM INC (CA) | 2002-06-12 | — | — | EP | disclosed |
| EP-1199566-A1 | Methods of screening affinity marker libraries | Conjuchem, Inc. (CA) | 2002-04-24 | — | — | EP | disclosed |
| EP-1056474-A2 | AFFINITY MARKERS FOR HUMAN SERUM ALBUMIN | ConjuChem, Inc. (CA) | 2000-12-06 | — | — | EP | disclosed |
| WO-1999024075-A2 | AFFINITY MARKERS FOR HUMAN SERUM ALBUMIN | CONJUCHEM, INC. (CA) | 1999-05-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050037974-A1 | Affinity markers for human serum albumin | ALB, FABP1, FCGR2A | BCL9 1244/4885CTNNB1 2337/4885SMN1; SMN2 4490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.